1.5% Ophthalmic Sodium Hyaluronate Gel 0.85ml is a sterile, nonpyrogenic, viscoelastic preparation of a highly purified, noninflammatory, high molecular weight fraction of sodium hyaluronate. Phacoemulsification with use of an OVD is the preferred technique of modern cataract surgery. The OVD maintains the anterior chamber, protects the corneal endothelium and facilitates IOL implantation.

1.5% Ophthalmic Sodium Hyaluronate Gel 0.85ml Indication:

1. Intraocular lens extraction and implantation

2. Corneal transplantation

3. Glaucoma operation

4. Retinal detachment

5. Eye injury and ophthalmic surgery

1.5% Ophthalmic Sodium Hyaluronate Gel 0.85ml Characteristics:

1. Colorless, transparent, uniform and isotonic gel.

2. No pyrogen, no antiger, no sensitive and allergic reaction.

3. High viscosity, elasticity and pseudo plasticity.

4. Better adhesion and spreading ability, protect corneal andothelial cells effectively.

5. Easy cleaning after the operation.

How Supplied 1.5% Ophthalmic Sodium Hyaluronate Gel 0.85ml

1.5% Ophthalmic Sodium Hyaluronate Gel 1.0ml is pre-filled with a physiologically balanced aqueous solution of sodium hyaluronate into a syringe. The syringe cone is covered with a protective cap and the package is equipped with a flushing needle in the pouch. The product is sterile through filtration sterilizing and aseptic process control, and can be used once.

Henan Universe Intraocular Lens Research and Manufacture Co., Ltd. was founded in 1991, is one of the first enterprises in China to produce intraocular lenses and related products. It has introduced advanced American technology and established a complete automated production line, integrating R&D, production, and sales. After 30 years of development, it has become China A benchmark enterprise in the field of intraocular lenses.

Till now, our company has products in sale, such as PMMA Intraocular Lens, Hydrophilic Acrylic Intraocular Lens, Glaucoma Drainage Implants, Hydroxypropyl Methylcellulose, Sodium Hyaluronate, Surgical Suture Needles with Thread, Disposal Injector for Foldable IOL and so on. Over 2 million Universe IOLs has been sold since their launch in 1991, with very low incidences of adverse effects and serious adverse events.

The highest eminence is to be gianed step by step.  Henan Universe Intraocular Lens Research and Manufacture Co., Ltd. will work hard and innovate constantly to improve the quantity of products, elevate the core competitiveness of the enterprise and make even greater contribution to the human health undertaking.